5-Imino-1-phenyl-4-(phenylhydrazinylidene)-3-pyrazolamine | 70649-20-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 5-Imino-1-phenyl-4-(phenylhydrazinylidene)-3-pyrazolamine
• 英文别名: 1-phenyl-4-phenyldiazenylpyrazole-3,5-diamine
• CAS: 70649-20-6
• 化学式: C₁₅H₁₄N₆
• 分子量: 278.316
• InChiKey: JDBSGKGTKLQVEM-UHFFFAOYSA-N

物化性质

• 沸点：
  536.6±50.0 °C(Predicted)
• 密度：
  1.34±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  94.6
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  5-Imino-1-phenyl-4-(phenylhydrazinylidene)-3-pyrazolamine 在 盐酸 、 sodium nitrite 作用下， 以 乙醇 、 水 、 溶剂黄146 为溶剂， 反应 3.5h， 生成 4-[4'-(phenyl)azo-3'-amino-1'-phenylpyrazole-5-ylazo]-3-methyl-1-phenylpyrazole-5-one
  参考文献：
  名称：

  Synthesis, Absorption Properties and Biological Evaluation of Some Novel Disazo Dyes Derived from Pyrazole Derivatives

  摘要：

  在本研究中，通过一种简便的方法合成了20种含吡唑衍生物的新型双偶氮染料。重氮化的苯胺及一些苯胺衍生物与丙二腈反应得到2-芳基偶氮丙二腈衍生物1(a-e)。合成的2-芳基偶氮丙二腈衍生物与肼和苯肼反应，分别得到相应的3,5-二氨基-4-芳基偶氮-1H-吡唑2(a-e)和3,5-二氨基-4-芳基偶氮-1-苯基吡唑3(a-e)。2(a-e)和3(a-e)的重氮化合物与乙酰乙酸乙酯反应得到4-芳基偶氮-3-氨基-1H-吡唑-5-偶氮-乙酰乙酸乙酯4(a-e)和4-芳基偶氮-3-氨基-1-苯基吡唑-5-偶氮-乙酰乙酸乙酯7(a-e)。所得的4(a-e)和7(a-e)分别与肼和苯肼反应，得到双偶氮染料5(a-e)、6(a-e)、8(a-e)和9(a-e)。合成的双偶氮染料通过光谱技术和元素分析进行表征。这些染料在不同溶剂中的溶剂化变色行为被研究。酸碱效应对染料最大吸收的影响也被报道。合成的双偶氮染料的抗菌活性也被研究。

  DOI：

  10.14233/ajchem.2015.18769
• 作为产物：
  描述：

  苯胺 在 盐酸 、 sodium nitrite 作用下， 生成 5-Imino-1-phenyl-4-(phenylhydrazinylidene)-3-pyrazolamine
  参考文献：
  名称：

  Synthesis, Absorption Properties and Biological Evaluation of Some Novel Disazo Dyes Derived from Pyrazole Derivatives

  摘要：

  在本研究中，通过一种简便的方法合成了20种含吡唑衍生物的新型双偶氮染料。重氮化的苯胺及一些苯胺衍生物与丙二腈反应得到2-芳基偶氮丙二腈衍生物1(a-e)。合成的2-芳基偶氮丙二腈衍生物与肼和苯肼反应，分别得到相应的3,5-二氨基-4-芳基偶氮-1H-吡唑2(a-e)和3,5-二氨基-4-芳基偶氮-1-苯基吡唑3(a-e)。2(a-e)和3(a-e)的重氮化合物与乙酰乙酸乙酯反应得到4-芳基偶氮-3-氨基-1H-吡唑-5-偶氮-乙酰乙酸乙酯4(a-e)和4-芳基偶氮-3-氨基-1-苯基吡唑-5-偶氮-乙酰乙酸乙酯7(a-e)。所得的4(a-e)和7(a-e)分别与肼和苯肼反应，得到双偶氮染料5(a-e)、6(a-e)、8(a-e)和9(a-e)。合成的双偶氮染料通过光谱技术和元素分析进行表征。这些染料在不同溶剂中的溶剂化变色行为被研究。酸碱效应对染料最大吸收的影响也被报道。合成的双偶氮染料的抗菌活性也被研究。

  DOI：

  10.14233/ajchem.2015.18769

文献信息

• Immugenic compositions and diagnostic and therapeutic uses thereof
  申请人：Zhang Zaihui

  公开号：US20050272709A1

  公开（公告）日：2005-12-08

  Pharmaceutical compositions and compounds are provided. The compounds of the invention deomonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, pharmaceutical compositions of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical compositions are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.

  本发明提供了制药组合物和化合物。本发明的化合物表现出抗增殖活性，并可能促进缺乏正常细胞周期和死亡调节的细胞凋亡。在本发明的一种实施例中，提供了化合物与生理可接受载体的制药组合物。这些制药组合物可用于治疗高增殖性疾病，包括肿瘤生长、淋巴增殖性疾病、血管生成等疾病。本发明的化合物是取代的吡唑和吡唑啉。
• Pyrazole compounds
  申请人：——

  公开号：US20030060453A1

  公开（公告）日：2003-03-27

  Pharmaceutical compositions and compounds are provided. The compounds of the invention demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, pharmaceutical compositions of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical compositions are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.

  本发明提供了药物组合物和化合物。该发明的化合物表现出抗增殖活性，并可能促进缺乏正常细胞周期和死亡调节的细胞凋亡。在本发明的一种实施方式中，提供了与生理可接受载体组合的化合物的药物组合物。这些药物组合物在治疗过度增生性疾病方面有用，这些疾病包括肿瘤生长、淋巴增生性疾病和血管生成。本发明的化合物是取代的吡唑和吡唑啉。
• Hydrazonopyrazole derivatives and their use as therapeutics
  申请人：Valocor Therapeutics, Inc.

  公开号：US07875728B2

  公开（公告）日：2011-01-25

  Pharmaceutical compositions and compounds are provided. The compounds of the invention demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, pharmaceutical compositions of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical compositions are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.

  本发明提供了药物组合物和化合物。本发明的化合物表现出抗增殖活性，并可能促进缺乏正常细胞周期和死亡调节的细胞凋亡。在本发明的一种实施例中，提供了化合物与生理上可接受的载体组合的药物组合物。这些药物组合物在治疗增生性疾病方面是有用的，这些疾病包括肿瘤生长，淋巴增生性疾病和血管生成。本发明的化合物是取代的吡唑和吡唑烷。
• HYDRAZONOPYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTICS
  申请人：Zhang Zaihui

  公开号：US20110237783A1

  公开（公告）日：2011-09-29

  Pharmaceutical compositions and compounds are provided. The compounds of the invention demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, pharmaceutical compositions of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical compositions are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.

  本发明提供了药物组合物和化合物。本发明的化合物表现出抗增殖活性，并可能促进缺乏正常细胞周期和死亡调节的细胞凋亡。在本发明的一个实施例中，提供了与生理学上可接受的载体结合的化合物的药物组合物。这些药物组合物在治疗增生性疾病方面有用，这些疾病包括肿瘤生长、淋巴增生性疾病和血管生成等疾病。本发明的化合物是取代的吡唑和吡唑啉。
• Synthesis, Absorption Properties and Biological Evaluation of Some Novel Disazo Dyes Derived from Pyrazole Derivatives
  作者：Nesrin Sener、Izzet Sener、Serkan Yavuz、Fikret Karci

  DOI：10.14233/ajchem.2015.18769

  日期：——

  In this study, 20 novel disazo dyes containing pyrazole derivatives were synthesized by a convenient method. Diazotized aniline and some aniline derivatives were reacted with malononitrile to give 2-arylazomalononitrile derivatives 1(a-e). The synthesized 2-arylazomalononitrile derivatives were reacted with hydrazine and phenyl hydrazine to afford the corresponding 3,5-diamino-4-arylazo-1H-pyrazole 2(a-e) and 3,5-diamino-4-arylazo-1-phenylpyrazole 3(a-e). Diazotized compounds of 2(a-e)and 3(a-e) reacted with ethylacetoacetate to give 4-arylazo-3-amino-1H-pyrazole-5-ylazo-ethylacetoacetate 4(a-e) and 4-arylazo-3-amino-1-phenylpyrazole-5-ylazo-ethylacetoacetate 7(a-e). The obtained 4(a-e) and 7(a-e) were reacted with hydrazine and phenyl hydrazine to give disazo dyes 5(a-e), 6(a-e), 8(a-e) and 9(a-e), respectively. The synthesized disazo dyes were characterized by spectroscopic techniques as well as elemental analysis. The solvatochromic behaviours of these dyes in various solvents were examined. Acid-base effects on the absorption maxima of the dyes were also reported. Antimicrobial activities of the synthesized novel disazo dyes were investigated.

  在本研究中，通过一种简便的方法合成了20种含吡唑衍生物的新型双偶氮染料。重氮化的苯胺及一些苯胺衍生物与丙二腈反应得到2-芳基偶氮丙二腈衍生物1(a-e)。合成的2-芳基偶氮丙二腈衍生物与肼和苯肼反应，分别得到相应的3,5-二氨基-4-芳基偶氮-1H-吡唑2(a-e)和3,5-二氨基-4-芳基偶氮-1-苯基吡唑3(a-e)。2(a-e)和3(a-e)的重氮化合物与乙酰乙酸乙酯反应得到4-芳基偶氮-3-氨基-1H-吡唑-5-偶氮-乙酰乙酸乙酯4(a-e)和4-芳基偶氮-3-氨基-1-苯基吡唑-5-偶氮-乙酰乙酸乙酯7(a-e)。所得的4(a-e)和7(a-e)分别与肼和苯肼反应，得到双偶氮染料5(a-e)、6(a-e)、8(a-e)和9(a-e)。合成的双偶氮染料通过光谱技术和元素分析进行表征。这些染料在不同溶剂中的溶剂化变色行为被研究。酸碱效应对染料最大吸收的影响也被报道。合成的双偶氮染料的抗菌活性也被研究。